Home Therapeutics Cross industry collaboration - Evaluating future synergies
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Therapeutics Cross industry collaboration - Evaluating future synergies
Cross industry collaboration - Evaluating future synergies
Price:
$4 295.00
Full Title: Cross industry collaboration - Evaluating future synergies among Pharma/Medical Device/Diagnostics sectors
Executive Summary
This latest strategic publication from HBS Consulting on Pharmaceutical /Medical Device/Diagnostics Licensing and Collaborations provides:
An insight into the market and an overview of the latest trends and collaborations between the different industry sectors.
A comprehensive analysis of opportunities for diagnostics and pharmaceutical companies within the area of personalised or individualised medicine.
An overview of opportunities and developments in combination drug- device products .
Evaluation methodologies and industry-specific strategic recommendations that may be used by companies that are seeking to benefit from diagnostics, medical devices and pharmaceutical alliances.
This report will help to explore and pinpoint emerging opportunities arising from collaborations between pharmaceutical, medical devices and diagnostic companies.
